Evidence and implications of pre‐existing humoral cross‐reactive immunity to SARS‐CoV‐2

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has emerged throughout the world. Building knowledge around Covid‐19 is crucial to devise facts based approaches to respond efficiently against this pandemic. AIM: We aimed to investigate pre‐existing humoral cross‐reactive imm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Immun Inflamm Dis
Autores principales: Mveang Nzoghe, Amandine, Essone, Paulin N., Leboueny, Marielle, Maloupazoa Siawaya, Anicet Christel, Bongho, Eliode Cyrien, Mvoundza Ndjindji, Ofilia, Avome Houechenou, Rotimi Myrabelle, Agnandji, Selidji Todagbe, Djoba Siawaya, Joel Fleury
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7860591/
https://ncbi.nlm.nih.gov/pubmed/33320447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iid3.367
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares